Aurora, CO Clinical Trials Report — April 2026

For Aurora, CO residents considering participation in clinical research, April 2026 presents a timely opportunity, especially with 65 clinical trials slated to conclude within the next 90 days. Among these, 9 trials are still actively seeking healthy volunteers, offering a unique chance to contribute to medical advancements without a specific health condition. Individuals interested in these opportunities should act promptly to explore their options.

New Research Opportunities in Aurora

This month, Aurora welcomed 10 new clinical trials, a slight increase from the 8 trials that opened in March 2026. This brings the total number of currently recruiting trials in Aurora to 988 across 322 research facilities. These new studies span a variety of conditions and research types, with a notable focus on behavioral interventions.

Among the new trials, several stand out due to their sponsors, participant numbers, or the conditions they address:

• The VA Office of Research and Development is sponsoring NCT07513805, "Implementation of Routine Walking Speed Measurements in Older Veterans." This large behavioral study aims to enroll 10,500 participants, investigating how walking speed, a key predictor of health outcomes, can inform care for older adults.
• Carelon Research is leading NCT07525843, "A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study." This behavioral trial seeks 390 participants to evaluate an online program designed to help teenagers with congenital heart disease manage stress.
• Children's Hospital Medical Center, Cincinnati, is sponsoring NCT07512622, "Asthma Ctrl SMART Trial." This behavioral study, targeting 389 participants, focuses on improving adherence to inhaled corticosteroids in adolescents with asthma through a mobile health intervention.
• The National Institute of Allergy and Infectious Diseases (NIAID) is initiating the Phase 2 study NCT07549503, "Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation." This drug trial plans for 100 participants and aims to determine the efficacy of reducing immunosuppression by 50 percent in liver transplant recipients.

The new trials cover conditions such as adolescent congenital heart disease, aging, asthma (both chronic and in children), congenital anomaly, fall risk, and high-risk neuroblastoma. Behavioral trials lead the way with 4 new studies, followed by 3 new drug trials, 1 device trial, 1 other type of trial, and 1 procedure trial.

Opportunities for Healthy Volunteers

For individuals without a specific medical condition, there are ongoing opportunities to contribute to medical research. This month, 1 of the 10 new trials is accepting healthy volunteers. More broadly, Aurora currently has 119 clinical trials recruiting healthy participants, providing numerous avenues for those interested in supporting medical science.

Key Research Facilities in Aurora

Aurora is home to several prominent research institutions that consistently run a high volume of clinical trials, making them central hubs for medical innovation and participation:

• Children's Hospital Colorado (166 trials)
• University of Colorado Anschutz Medical Campus (90 trials)
• University of Colorado (81 trials)
• UCHealth University of Colorado Hospital (57 trials)
• University of Colorado Hospital (44 trials)
• University of Colorado Cancer Center (36 trials)
• University of Colorado Denver (29 trials)
• Rocky Mountain Regional VA Medical Center, Aurora, CO (25 trials)
• Rocky Mountain Cancer Centers-Aurora (20 trials)

These facilities, including the specialized Children's Hospital Colorado and the University of Colorado Cancer Center, offer a broad spectrum of research opportunities, from pediatric health to advanced oncology and veteran care.

Trials Closing Soon: Conditions to Note

As 65 trials approach their enrollment deadlines, patients managing certain health conditions should be aware of these impending closures. Conditions with trials closing soon include:

• Breast cancer (3 trials)
• Myasthenia gravis (2 trials)
• B-cell acute lymphoblastic leukemia (2 trials)
• Metastatic undifferentiated pleomorphic sarcoma (2 trials)
• Unresectable undifferentiated pleomorphic sarcoma (2 trials)
• Unresectable dedifferentiated liposarcoma (2 trials)
• Cystic fibrosis (2 trials)
• Migraine (2 trials)
• Headache (2 trials)
• Metastatic dedifferentiated liposarcoma (2 trials)

These represent critical windows for individuals with these conditions to explore potential new treatments or interventions.

Participation Demographics and Nearby Options

The new trials opening this month are inclusive, with 7 studies designed to include children and 5 studies specifically including older adults. No new trials are exclusively for female or male participants. Academic institutions, particularly the University of Colorado, Denver, are significant sponsors of new research, alongside industry sponsors like Carelon Research and federal agencies such as the National Institute of Allergy and Infectious Diseases (NIAID).

While Aurora offers a robust selection of clinical trial opportunities, residents may also find options in nearby Colorado cities. Active trials are currently recruiting in Denver (5 trials), Louisville (2 trials), Broomfield (1 trial), and Colorado Springs (1 trial), providing additional avenues for participation.

As we move through April, Aurora's research community continues to drive medical innovation, offering diverse opportunities for patients and healthy volunteers to contribute to the future of healthcare. The focus remains on advancing treatments across various conditions and understanding new approaches to health and well-being.